Chronic inflammatory demyelinating polyneuropathy and paraproteinemic neuropathies.
Chronic inflammatory demyelinating polyneuropathy and the neuropathies associated with monoclonal gammopathies represent a significant proportion of initially undiagnosed neuropathies. Over the past year, a number of publications have provided information on the clinical characteristics, mechanisms, and possible relationships between these neuropathies. This review summarizes this recent information, with an emphasis on the relevance to therapy.
Glass
J D
JD
Department of Neurology, Johns Hopkins University School of Medicine Pathology, Baltimore, MD 21287.
Cornblath
D R
DR
D002908:Chronic Disease; D003711:Demyelinating Diseases / Q000145:classification / Q000175:diagnosis* / Q000628:therapy; D006801:Humans; D009460:Neurologic Examination; D010265:Paraproteinemias / Q000145:classification / Q000175:diagnosis* / Q000628:therapy; D010266:Paraproteins / Q000378:metabolism; D010951:Plasma Exchange; D011115:Polyneuropathies / Q000145:classification / Q000175:diagnosis* / Q000628:therapy; D011129:Polyradiculoneuropathy / Q000145:classification / Q000175:diagnosis* / Q000628:therapy
D010266:Paraproteins